SDC2 and hepatocellular carcinoma: Glypican-3 expression levels are higher in HCC than in surrounding normal tissues; thus, glypican-3 is a HSPG commonly targeted by biologics such as chimeric antigen receptors, bispecific antibodies, and immunotoxins (Fu et al. 2023).